Arkolith/Insider Trading/KURA/Form 4

Burrows Francis

Chief Scientific OfficerKura Oncology, Inc. (KURA) · full profile →Form 4 · filed Jan 28, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$17K
Net Open-Market Flow
-$17K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 28, 2025Sell(S)1K$7.87$10K21K
Jan 28, 2025Sell(S)846$7.87$7K22K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-010117) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML